The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils. myarzi12019-03-26T13:18:41+00:00Netazepide| Read More
Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects. myarzi12019-03-26T13:19:12+00:00Netazepide| Read More
Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects. myarzi12019-03-26T13:19:44+00:00Netazepide| Read More
The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression. myarzi12019-03-26T13:20:31+00:00Netazepide| Read More
Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects. myarzi12019-03-26T13:20:58+00:00Uncategorized| Read More
